3326 - 3350 of 9156 Results
Title
Year
-
OPENTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://doi.org/10.1038/s41531-017-0010-8Citation Count: 306
-
OPENTitle: Declining Quality of Life in Parkinson Disease Before and After DiagnosisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 2Issue #: 2Start Page: 153End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-12083Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3744127Citation Count: 13
-
OPENTitle: A GCase Chaperone Improves Motor Function in a Mouse Model of SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 840End Page: 856Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0294-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-014-0294-x.pdfCitation Count: 107
-
OPENTitle: Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 DomainJournal Name: Molecular and Cellular BiologyPublisher: Informa UK LimitedVol: 34Issue #: 12Start Page: 2147End Page: 2161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/mcb.00914-13Best OA location URL: https://mcb.asm.org/content/mcb/34/12/2147.full.pdfCitation Count: 114
-
OPENTitle: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal FluidJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 1Start Page: 217End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-015-0404-4Best OA location URL: http://doi.org/10.1007/s13311-015-0413-3Citation Count: 45
- Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic Proteins2018RESTRICTEDTitle: Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic ProteinsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 369End Page: 386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-7811-3_24Citation Count: 20
-
OPENTitle: Analysis of Mitochondrial haemoglobin in Parkinson's disease brainJournal Name: MitochondrionPublisher: Elsevier BVVol: 29Issue #:Start Page: 45End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001Best OA location URL: https://doi.org/10.1016/j.mito.2016.05.001Citation Count: 28
-
OPENTitle: Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem CellsJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 355End Page: 366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-60761-369-5_19Best OA location URL: http://doi.org/10.1007/978-1-60761-369-5_19Citation Count: 99
-
OPENTitle: Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studiesJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page: 16End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1756-6606-1-16Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/1756-6606-1-16Citation Count: 23
-
OPENTitle: Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s DiseaseJournal Name: LungPublisher: Springer Science and Business Media LLCVol: 192Issue #: 4Start Page: 601End Page: 608Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00408-014-9584-7Best OA location URL: http://doi.org/10.1007/s00408-014-9584-7Citation Count: 94
-
OPENTitle: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal PersonsJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 317Issue #: 22Start Page: 2305End Page: 2305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2017.6669Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2631529/jama_donohue_2017_oi_170051.pdfCitation Count: 477
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 20
-
OPENTitle: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial designJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 22Issue #:Start Page: 100785End Page: 100785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100785Citation Count: 17
- The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study2015RESTRICTEDTitle: The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 4Start Page: 1736End Page: 1742Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.037Citation Count: 50
-
OPENTitle: Telemedicine Care for Nursing Home Residents with ParkinsonismJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 64Issue #: 1Start Page: 218End Page: 220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jgs.13909Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.13909Citation Count: 20
-
OPENTitle: Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 218Issue #:Start Page: 107222End Page: 107222Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107222Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107222Citation Count: 0
- Regional gray matter changes and age predict individual treatment response in Parkinson's disease2018OPENTitle: Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 21Issue #:Start Page: 101636End Page: 101636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636Best OA location URL: https://doi.org/10.1016/j.nicl.2018.101636Citation Count: 26
- A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease2023RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
-
OPENTitle: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 143.e1End Page: 143.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7302975Citation Count: 21
- Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”2025RESTRICTEDTitle: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 10Start Page: 2287End Page: 2288Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.70053Citation Count: 0
-
OPENTitle: Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's DiseaseJournal Name: EBioMedicinePublisher: Elsevier BVVol: 2Issue #: 11Start Page: 1785End Page: 1798Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2015.09.053Best OA location URL: http://www.ebiomedicine.com/article/S2352396415301687/pdfCitation Count: 59
-
OPENTitle: SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27770Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7322732Citation Count: 28
-
OPENTitle: Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12589Citation Count: 1
- Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke2015RESTRICTEDTitle: Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic StrokeJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 2Start Page: 302End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00259Citation Count: 72